| Item Type | Name |
|
Concept
|
Angina, Stable
|
|
Academic Article
|
Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group.
|
|
Academic Article
|
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
|
|
Academic Article
|
Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina.
|
|
Academic Article
|
Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.
|
|
Academic Article
|
Management of Stable Angina - Current Guidelines: A Critical Appraisal.
|
|
Academic Article
|
Drug Therapy for Stable Angina Pectoris.
|
|
Academic Article
|
Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence.
|
|
Academic Article
|
Short and long-acting oral nitrates for stable angina pectoris.
|
|
Academic Article
|
Ointments and transdermal nitroglycerin patches for stable angina pectoris.
|
|
Academic Article
|
Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial.
|
|
Academic Article
|
Treatment of stable angina.
|
|
Academic Article
|
Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris.
|
|
Academic Article
|
Prevention of nitrate tolerance with angiotensin II receptor type 1 blocker in patients with stable angina: yet another failed strategy to prevent tolerance.
|
|
Academic Article
|
Therapy of stable angina pectoris: the uncomplicated patient.
|
|
Academic Article
|
Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
|
|
Academic Article
|
Medical therapy of stable angina pectoris.
|
|
Academic Article
|
Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.
|
|
Academic Article
|
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
|
|
Academic Article
|
Choosing the most appropriate treatment for stable angina. Safety considerations.
|
|
Academic Article
|
Current medical management of chronic stable angina.
|
|
Academic Article
|
Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial.
|
|
Academic Article
|
Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics.
|
|
Academic Article
|
Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.
|
|
Academic Article
|
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
|
|
Academic Article
|
Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris.
|
|
Academic Article
|
Selection of optimal therapy for chronic stable angina.
|
|
Academic Article
|
Exercise performance, physical activity, and health-related quality of life in participants with stable angina.
|
|
Academic Article
|
A randomized, double-blind, placebo-controlled, crossover, dose-ranging multicenter study to determine the effect of sublingual nitroglycerin spray on exercise capacity in patients with chronic stable angina.
|
|
Academic Article
|
Chronic stable angina pectoris.
|
|
Academic Article
|
Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
|
|
Academic Article
|
Chronic stable angina pectoris. Strategies for effective drug therapy.
|
|
Academic Article
|
Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators.
|
|
Academic Article
|
Management of patients with chronic stable angina at low risk for serious cardiac events.
|